Ray Dalio’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.3M Sell
115,229
-101,440
-47% -$21.8M 0.11% 132
2025
Q4
$44.5M Sell
216,669
-55,364
-20% -$10.4M 0.16% 98
2025
Q3
$42.7M Buy
272,033
+13,278
+5% +$2.05M 0.17% 96
2025
Q2
$43.5M Buy
258,755
+186,472
+258% +$27.7M 0.18% 99
2025
Q1
$9.96M Sell
72,283
-336,472
-82% -$42.9M 0.05% 262
2024
Q4
$48.3M Sell
408,755
-56,504
-12% -$6.6M 0.22% 84
2024
Q3
$51.4M Sell
465,259
-5,557
-1% -$581K 0.29% 64
2024
Q2
$46.3M Sell
470,816
-80,612
-15% -$8.21M 0.24% 70
2024
Q1
$61.7M Buy
551,428
+133,009
+32% +$14.4M 0.31% 64
2023
Q4
$42.2M Sell
418,419
-42,581
-9% -$4.22M 0.24% 77
2023
Q3
$40M Buy
461,000
+171,038
+59% +$15.5M 0.24% 82
2023
Q2
$27.4M Buy
289,962
+81,028
+39% +$6.84M 0.17% 107
2023
Q1
$15.8M Sell
208,934
-31,050
-13% -$2.34M 0.1% 156
2022
Q4
$18.4M Buy
239,984
+172,026
+253% +$13.1M 0.1% 164
2022
Q3
$4.53M Sell
67,958
-446,545
-87% -$28.3M 0.02% 401
2022
Q2
$26.9M Buy
514,503
+105,553
+26% +$6M 0.11% 162
2022
Q1
$23.2M Buy
408,950
+84,341
+26% +$4.52M 0.09% 158
2021
Q4
$16.7M Buy
324,609
+29,349
+10% +$1.44M 0.1% 137
2021
Q3
$14.6M Buy
295,260
+9,927
+3% +$539K 0.08% 156
2021
Q2
$16.3M Buy
285,333
+121,240
+74% +$7.08M 0.1% 152
2021
Q1
$9.97M Buy
164,093
+14,477
+10% +$799K 0.09% 162
2020
Q4
$8.01M Buy
149,616
+78,954
+112% +$4.1M 0.07% 151
2020
Q3
$3.32M Buy
70,662
+65,634
+1,305% +$3.37M 0.04% 187
2020
Q2
$262K Sell
5,028
-3,275
-39% -$169K ﹤0.01% 347
2020
Q1
$398K Buy
+8,303
New +$431K 0.01% 310
2019
Q4
Sell
-349,452
Closed -$16.5M 488
2019
Q3
$16.5M Sell
349,452
-125,851
-26% -$5.74M 0.14% 69
2019
Q2
$22.4M Sell
475,303
-61,315
-11% -$2.83M 0.18% 53
2019
Q1
$25.8M Sell
536,618
-245,425
-31% -$12.3M 0.16% 38
2018
Q4
$34.9M Buy
782,043
+603,494
+338% +$31.5M 0.32% 39
2018
Q3
$9.64M Sell
178,549
-574,357
-76% -$29.4M 0.1% 75
2018
Q2
$36.8M Buy
752,906
+146,124
+24% +$8.29M 0.37% 24
2018
Q1
$38M Buy
606,782
+131,090
+28% +$8.99M 0.36% 23
2017
Q4
$29.1M Buy
+475,692
New +$29.4M 0.24% 22
2017
Q2
Sell
-46,958
Closed -$3.83M 351
2017
Q1
$3.83M Sell
46,958
-77,042
-62% -$6.06M 0.04% 113
2016
Q4
$8.92M Buy
124,000
+26,743
+27% +$1.93M 0.08% 84
2016
Q3
$7.56M Sell
97,257
-46,324
-32% -$3.74M 0.07% 91
2016
Q2
$11.2M Buy
143,581
+50,149
+54% +$4M 0.14% 60
2016
Q1
$7.66M Buy
93,432
+29,100
+45% +$2.37M 0.1% 80
2015
Q4
$5.74M Sell
64,332
-26,400
-29% -$2.24M 0.07% 109
2015
Q3
$6.97M Sell
90,732
-18,568
-17% -$1.55M 0.09% 104
2015
Q2
$9.14M Buy
109,300
+39,300
+56% +$3.47M 0.08% 51
2015
Q1
$6.32M Buy
+70,000
New +$6.03M 0.05% 106
2014
Q3
Sell
-10,834
Closed -$743K 371
2014
Q2
$743K Sell
10,834
-38,010
-78% -$2.59M 0.01% 242
2014
Q1
$3.42M Buy
48,844
+23,198
+90% +$1.61M 0.03% 141
2013
Q4
$1.71M Sell
25,646
-49,700
-66% -$3.04M 0.01% 176
2013
Q3
$3.93M Buy
75,346
+29,000
+63% +$1.47M 0.03% 118
2013
Q2
$2.19M Buy
+46,346
New +$2.12M 0.02% 151

Other funds holding CAH

Ray Dalio's CAH Position: Q1 2026 in Review

Ray Dalio reduced its Cardinal Health (CAH) stake by 47% in Q1 2026, selling an estimated $21.8M and leaving 115,229 shares worth $24.3M. The position accounts for 0.11% of the portfolio, ranked #132.

Ray Dalio first reported a position in CAH in Q2 2013 and has held it in 47 quarters since. The position peaked at $61.7M in Q1 2024. 1,429 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Ray Dalio held 115,229 shares of Cardinal Health worth $24.3M as of Q1 2026.
  • Ray Dalio sold 101,440 Cardinal Health shares in Q1 2026, an estimated $21.8M.
  • Cardinal Health made up 0.11% of Ray Dalio's portfolio in Q1 2026, its #132 holding.
  • Ray Dalio first reported a position in Cardinal Health in Q2 2013 and has held it in 47 quarters since.
  • Ray Dalio's Cardinal Health position peaked at $61.7M in Q1 2024.
  • 1,429 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.